Exact Sciences is committed to helping win the war on cancer through early detection.

Learn More

Cologuard: the first and only FDA approved stool DNA noninvasive colorectal cancer screening test.*

Learn More about Cologuard
*For average risk individuals only. Click the link above and talk to your doctor to see if Cologuard is right for you.

Latest News

Exact Sciences Aims to Collaborate with City of Madison & University of Wisconsin in Developing a Biotech Campus

Madison-Based Manufacturer of Cologuard Focuses on a Scalable Environment that Expands Existing Footprint MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS) announced today that it will continue collaborating with the City of Madison in an attempt to establish a headquarters in Madison and is in discussions with the University of Wisconsin to develop a biotech campus that...Read more

Cologuard(R) Growth Trajectory Increases to 34,000 Completed Tests, Generates $12.6M in Revenue in Third Quarter 2015

  MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (Nasdaq:EXAS) today announced that the company continued its strong performance during the third quarter ended Sept. 30, 2015, completing 34,000 Cologuard tests, an increase of 60 percent from the second quarter, which resulted in $12.6 million in revenues. The cumulative number of ordering physicians grew to 21,000 during the quarter,...Read more

Be Seen, Get Screened
1 in 3 is not getting screened for colon cancer. Let's bring everyone out of hiding and in to get screened. Join us on Be Seen, Get Screened to help spread the word.

Exact Sciences Laboratories is dedicated to delivering the most accurate results and providing physicians and patients with world-class service.

Go To ExactLabs.com


View updates on upcoming conference appearances, company news, financial reports and more.

Learn More